Our investigation has revealed that cancer stem cell-derived exosomal LUCAT1 enhances the stemness phenotype and chemoresistance of bladder cancer cells by upregulating HMGA1 expression through its interaction with IGF2BP2, thereby contributing to the oncogenicity of bladder cancer. The gene discussed is LUCAT1; the disease is urinary bladder cancer.